The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 25, 2022

Filed:

Feb. 11, 2020
Applicant:

National Institute of Biological Sciences, Beijing, Beijing, CN;

Inventors:

Zhiyuan Zhang, Beijing, CN;

Xiaodong Wang, Beijing, CN;

Yaning Su, Beijing, CN;

Hanying Ruan, Beijing, CN;

Yan Ren, Beijing, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/165 (2006.01); A61K 31/10 (2006.01); A61K 31/167 (2006.01); C07C 233/01 (2006.01); C07C 235/38 (2006.01); C07D 231/02 (2006.01); C07D 263/04 (2006.01); C07D 205/04 (2006.01); C07D 265/30 (2006.01); C07D 207/12 (2006.01); C07D 211/70 (2006.01); C07D 231/04 (2006.01); C07D 231/08 (2006.01); C07D 233/38 (2006.01); C07D 405/04 (2006.01); C07D 409/04 (2006.01); C07D 241/04 (2006.01); C07D 417/04 (2006.01); C07D 261/02 (2006.01); C07D 263/22 (2006.01); C07D 203/18 (2006.01); C07D 205/08 (2006.01); C07D 207/06 (2006.01); C07D 207/08 (2006.01); C07D 207/20 (2006.01); C07D 207/24 (2006.01); C07D 207/27 (2006.01); C07D 207/333 (2006.01); C07D 211/16 (2006.01); C07D 211/82 (2006.01); G01C 19/5649 (2012.01); G01C 19/5747 (2012.01);
U.S. Cl.
CPC ...
A61K 31/165 (2013.01); A61K 31/10 (2013.01); A61K 31/167 (2013.01); C07C 233/01 (2013.01); C07C 235/38 (2013.01); C07D 203/18 (2013.01); C07D 205/04 (2013.01); C07D 205/08 (2013.01); C07D 207/06 (2013.01); C07D 207/08 (2013.01); C07D 207/12 (2013.01); C07D 207/20 (2013.01); C07D 207/24 (2013.01); C07D 207/27 (2013.01); C07D 207/333 (2013.01); C07D 211/16 (2013.01); C07D 211/70 (2013.01); C07D 211/82 (2013.01); C07D 231/02 (2013.01); C07D 231/04 (2013.01); C07D 231/08 (2013.01); C07D 233/38 (2013.01); C07D 241/04 (2013.01); C07D 261/02 (2013.01); C07D 263/04 (2013.01); C07D 263/22 (2013.01); C07D 265/30 (2013.01); C07D 405/04 (2013.01); C07D 409/04 (2013.01); C07D 417/04 (2013.01); G01C 19/5649 (2013.01); G01C 19/5747 (2013.01);
Abstract

The invention provides amides that inhibit cellular necrosis and/or human receptor interacting protein 1 kinase (RIP1), including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.


Find Patent Forward Citations

Loading…